Despite not yet receiving approval, Revolution Medicines' pancreatic cancer drug is already the subject of discussions regarding its potential expanded applications.
As researchers work on developing treatments and vaccines for hantavirus, recent outbreaks highlight the urgency of their efforts amid limited funding.
Recent monitoring has detected elevated levels of antidepressants in waterways, prompting worries about their potential environmental and health effects.
Stay informed about hantavirus and other health news, including updates on the abortion pill and paternal deaths, as shared in Morning Rounds.
Recent budget cuts to NIH-funded research centers are hindering their ability to maintain crucial relationships with experts needed for effective outbreak responses.
NewLimit, a longevity-focused startup, has successfully raised $435 million in funding, which will support its first clinical trial targeting liver medicine.
Aarhus University researchers are creating a model to improve understanding of soil invertebrates, aligning with the EU's Soil Strategy for 2030.
A recent study suggests that while genetics can influence relationship breakdown, they are not the only factor at play. This insight could inform relationship counseling practices.
This piece outlines the key statutory requirements and policies that have shaped U.S. efforts in global family planning and reproductive health over the years.
A recent report highlights how a state's medical meal program has contributed to lowering health care costs, alongside other health news including Medicaid work requirements and Ebola vaccine funding.
As states increase scrutiny on corporate medicine, the telehealth sector faces significant challenges. The focus is on the corporate frameworks that support direct-to-consumer services.
Emergency physician Iyesatta Massaquoi Emeli argues for a complete redesign of how patients interact with the healthcare system, moving beyond traditional waiting rooms.
A European research team aims to revolutionize everyday products by creating sustainable alternatives to fossil resource-based materials.
A recent study suggests that assistance policies enacted during the COVID-19 pandemic may have played a significant role in improving food security and housing stability.
Innovative low-dose immunotherapies could potentially enable patients in poorer countries to receive advanced cancer treatments that are typically out of reach.
In Central Africa, millions depend on wild meat for sustenance, particularly in rural regions near the Congo rainforest. Banning this resource could worsen food insecurity.
Ivonescimab, a lung cancer treatment from China, garnered attention at ASCO for its potential to extend survival in patients with squamous cell lung cancer, though experts urge for trials involving a more diverse patient base.
A new study indicates that initiating hormone therapy before surgery may lead to lower relapse rates in prostate cancer patients, suggesting a shift in treatment strategies.
Recent findings presented at ASCO indicate significant progress in targeting a key component of pancreatic cancer, referred to as a 'greasy ball'.
Mark Goldsmith, CEO of Revolution Medicines, has announced the upcoming submission of daraxonrasib for FDA approval as the company begins shipping the experimental drug.